(S (NP (JJ Clinical) (NNS trials)) (VP (VBP are) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (JJ Evidence-Based) (NNP Medicine))))) (. .))
(S (NP (JJ Trial) (NNS results)) (VP (VBP are) (VP (VBN reviewed) (PP (IN by) (NP (NP (NNS experts)) (CC and) (NP (NN consensus) (NNS panels)))) (PP (IN for) (S (VP (VBG producing) (NP (NP (NNS meta-analyses)) (CC and) (NP (JJ clinical) (NN practice) (NNS guidelines)))))))) (. .))
(S (S (ADVP (RB However)) (, ,) (S (VP (VBG reviewing) (NP (DT these) (NNS results)))) (VP (VBZ is) (NP (DT a) (ADJP (JJ long) (CC and) (JJ tedious)) (NN task)))) (, ,) (S (ADVP (RB hence)) (NP (DT the) (NNS meta-analyses) (CC and) (NNS guidelines)) (VP (VBP are) (RB not) (VP (VBN updated) (NP (NP (DT each) (NN time)) (SBAR (S (NP (DT a) (JJ new) (NN trial)) (VP (VBZ is) (VP (VBN published))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (NN independence)) (PP (IN of) (NP (NNS experts)))) (VP (MD may) (VP (VB be) (ADJP (JJ difficult) (SBAR (S (VP (TO to) (VP (VB appraise)))))))) (. .))
(S (PP (IN On) (NP (DT the) (JJ contrary))) (, ,) (PP (IN in) (NP (NP (JJ many) (JJ other) (NNS domains)) (, ,) (PP (VBG including) (NP (JJ medical) (NN risk) (NN analysis))) (, ,))) (NP (NP (DT the) (NN advent)) (PP (IN of) (NP (NP (NNS data) (NN science)) (, ,) (NP (JJ big) (NNS data)) (CC and) (NP (JJ visual) (NNS analytics))))) (VP (VBD allowed) (S (VP (VBG moving) (PP (IN from) (ADJP (JJ expert-based))) (PP (TO to) (NP (JJ fact-based) (NN knowledge)))))) (. .))
(S (PP (IN Since) (NP (CD 12) (NNS years))) (, ,) (NP (JJ many) (NN trial) (NNS results)) (VP (VBP are) (ADJP (RB publicly) (JJ available)) (ADVP (NN online)) (PP (IN in) (NP (NN trial) (NNS registries)))) (. .))
(S (ADVP (RB Nevertheless)) (, ,) (NP (NNS data) (NN science) (NNS methods)) (VP (VBP have) (RB not) (ADVP (RB yet)) (VP (VBN been) (VP (VBN applied) (ADVP (RB widely)) (PP (TO to) (NP (NN trial) (NNS data)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (NN platform)) (PP (IN for) (S (VP (VBG analyzing) (NP (NP (DT the) (NN safety) (NNS events)) (VP (VP (VBD reported) (PP (IN during) (NP (JJ clinical) (NNS trials)))) (CC and) (VP (VBN published) (PP (IN in) (NP (NN trial) (NNS registries))))))))))) (. .))
(S (NP (DT This) (NN platform)) (VP (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT an) (JJ ontological) (NN model)) (PP (VBG including) (NP (NP (CD 582) (NNS trials)) (PP (IN on) (NP (NN pain) (NNS treatments))))))))) (, ,) (CC and) (VP (VBZ uses) (NP (JJ semantic) (NN web) (NNS technologies)) (PP (IN for) (S (VP (VBG querying) (NP (DT this) (NN dataset)) (PP (IN at) (NP (NP (JJ various) (NNS levels)) (PP (IN of) (NP (NN granularity)))))))))) (. .))
(S (NP (PRP It)) (ADVP (RB also)) (VP (VBZ relies) (PP (IN on) (NP (DT a) (JJ 26-dimensional) (NN flower) (NN glyph))) (PP (IN for) (NP (NP (DT the) (NN visualization)) (PP (IN of) (NP (NP (DT the) (NNP Adverse) (NNP Drug) (NNP Events) (PRN (-LRB- -LRB-) (NP (NNP ADE)) (-RRB- -RRB-)) (NNS rates)) (PP (IN in) (NP (NP (CD 13) (NNS categories)) (CC and) (NP (NP (CD 2) (NNS levels)) (PP (IN of) (NP (NN seriousness))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBP illustrate) (NP (NP (DT the) (NN interest)) (PP (IN of) (NP (DT this) (NN platform)))) (PP (IN through) (NP (JJ several) (NN use) (NNS cases))))) (CC and) (S (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB find) (ADVP (JJ back)) (NP (NP (NNS conclusions)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (PP (IN in) (NP (DT the) (NN literature)))))))))))))) (. .))
(S (NP (DT The) (NN platform)) (VP (VP (VBD was) (VP (VBN presented) (PP (TO to) (NP (NP (CD four) (NNS experts)) (PP (IN in) (NP (NN drug) (NN safety))))))) (, ,) (CC and) (VP (VBZ is) (ADJP (RB publicly) (JJ available)) (ADVP (NN online)) (, ,) (PP (IN with) (NP (NP (DT the) (NN ontology)) (PP (IN of) (NP (NN pain) (NN treatment) (NNP ADE))))))) (. .))
